Related Experiment Video
Updated: Jun 28, 2026
09:53
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
[Coma: etiology, diagnosis, and treatment].
Dalia Adukauskiene1, Brigita Budryte, Diana Karpec
1Department of Intensive Care, Kaunas University of Medicine, Kaunas, Lithuania. daliaadu@gmail.com
Medicina (Kaunas, Lithuania)
|November 13, 2008
Summary
Coma, a disorder of consciousness, results from brain damage and has neurogenic, metabolic, or toxic causes. Diagnosis involves neurological exams and lab tests, with treatment tailored to the cause for better patient outcomes.
Area of Science:
- Neurology
- Critical Care Medicine
Context:
- Coma is a severe disorder of consciousness resulting from damage to the cerebral cortex or reticular activating system.
- It can stem from neurogenic (e.g., traumatic brain injury), metabolic, or toxic factors.
Purpose:
- To outline the diagnostic approaches and treatment strategies for various types of coma.
- To emphasize the importance of timely and appropriate medical intervention.
Summary:
- Diagnostic evaluation includes laboratory tests for metabolic/toxic coma and comprehensive neurological examinations (assessing consciousness, pupils, oculomotor, motor, and cardiopulmonary systems) for neurogenic coma.
- Management focuses on ensuring adequate oxygenation and circulatory support.
- Treatment varies by cause: specific protocols for metabolic coma, antidotes for toxic coma, and surgical intervention for traumatic brain injury.
Impact:
- Effective diagnosis and management are crucial for improving prognosis.
- Patient outcomes are influenced by age, comorbidities, cause of coma, and quality of medical care.
Related Concept Videos
01:26Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...